🔎 Trials Near Me

Dachaigh › Galar Ae Steatotic › Arizona › Tucson

Sgrùdaidhean clionaigeach Galar Ae Steatotic ann an Tucson, AZ

Tha 10 sgrùdaidhean airson Galar Ae Steatotic a’ lorg phàirtichean aig làraichean ann agus timcheall air Tucson (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

A’ fastadhÌre 3
  • 89bio Clinical Study Site, Tucson
  • 89bio Clinical Study Site, Tucson
  • 89bio Clinical Study Site, Tucson
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

A’ fastadhÌre 3
  • 89bio Clinical Study Site, Tucson
  • 89bio Clinical Study Site, Tucson
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06318169

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

A’ fastadhÌre 2
  • Arizona Liver Health - Tucson, Tucson
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07527910

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

A’ fastadhÌre 2
  • Adobe Clinical Research, Tucson
  • Arizona Liver Health - Tucson, Tucson
  • Del Sol Research Management, LLC, Tucson
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

A’ fastadhÌre 3
  • The Institute for Liver Health II dba Arizona Clinical Trials - Tucson, Tucson
  • Del Sol Research Management, LLC, Tucson
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

A’ fastadhÌre 3
  • Akero Clinical Study Site, Tucson
  • Akero Clinical Study Site, Tucson
  • Akero Clinical Study Site, Tucson
  • agus 1 a bharrachd
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06528314

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

A’ fastadhÌre 2
  • Adobe Clinical Research, LLC, Tucson
  • Arizona Liver Health - Tucson, Tucson
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07288138

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

A’ fastadhÌre 2
  • GSK Investigational Site, Tucson
  • GSK Investigational Site, Tucson
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

A’ fastadhÌre 3
  • GSK Investigational Site, Tucson
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

A’ fastadhÌre 2
  • GSK Investigational Site, Tucson
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06920043

Sgrùdaidhean Galar Ae Steatotic ann am bailtean eile

Sgrùdaidhean eile ann an Tucson

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.